Cancer Prevention and Research Institute of Texas Awards $7.5 Million to Baylor Scott & White Research Institute

Baylor Scott & White Research Institute will establish the Texas site of the Connect for Cancer Prevention StudyTM (Connect), a project of the National Cancer Institute (NCI), part of the National Institutes of Health. Nine healthcare systems plan to enroll 200,000 adults across the U.S.

UAH to feature AI, cybersecurity, directed energy, aerial systems and more at 2023 Space & Missile Defense Symposium

The University of Alabama in Huntsville (UAH), a part of the University of Alabama System, will highlight its extensive capabilities in artificial intelligence, cybersecurity, directed energy, information systems, rotorcraft systems, supply chain management and hypersonics during the Space & Missile Defense (SMD) Symposium at the Von Braun Center in Huntsville, Ala.

NIH-funded UAH research moving toward day when ultrasonic therapy makes stronger knees

Low-intensity ultrasound therapies may one day rebuild stronger knees following injury or surgery, thanks to research by Dr. Anu Subramanian at The University of Alabama in Huntsville (UAH) that’s being supported by the National institutes of Health.

Sanford Burnham Prebys selected for participation in National Cancer Institute Chemical Biology Consortium

For the third time, Sanford Burnham Prebys has been selected by the Frederick National Laboratory for Cancer Research, currently operated by Leidos Biomedical Research, Inc., supporting the NCI Experimental Therapeutics (NExT) Program as a Center for the Chemical Biology Consortium (CBC).

Johns Hopkins receives $1.6 million NIH grant to commercialize innovations to treat substance use disorders

Johns Hopkins Carey Business School faculty, along with School of Medicine colleagues, will create a cutting-edge pathway for substance use disorder researchers to develop new treatment options thanks to a $1.6 million grant from the National Institute on Drug Abuse, which does not typically award grants to business schools.

UTHealth joins NIH trial to test antibodies and other experimental outpatient treatments for mild COVID-19 pneumonia

A study on the effectiveness of multiple treatments, including laboratory-made antibodies, at preventing mild COVID-19 from advancing to severe illness in the outpatient setting is underway by researchers at The University of Texas Health Science Center at Houston (UTHealth). The clinical trial is enrolling patients at Harris Health System’s Lyndon B. Johnson Hospital.

UC San Diego Researchers Optimize Microbiome Tool for Computer GPUs

University of California San Diego researchers have ported the popular UniFrac microbiome tool to graphic processing units (GPUs) in a bid to increase the acceleration and accuracy of scientific discovery, including urgently needed COVID-19 research.